KNOTUS Financial Statements From 2010 to 2024
| 278650 Stock | KRW 1,980 25.00 1.25% |
Check KNOTUS CoLtd financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among KNOTUS CoLtd's main balance sheet or income statement drivers, such as , as well as many indicators such as . KNOTUS financial statements analysis is a perfect complement when working with KNOTUS CoLtd Valuation or Volatility modules.
KNOTUS |
KNOTUS CoLtd Company Shares Owned By Insiders Analysis
KNOTUS CoLtd's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current KNOTUS CoLtd Shares Owned By Insiders | 49.21 % |
Most of KNOTUS CoLtd's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, KNOTUS CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 49.21% of KNOTUS CoLtd are shares owned by insiders. This is 224.18% higher than that of the Healthcare sector and significantly higher than that of the Biotechnology & Medical Research industry. The shares owned by insiders for all Republic of Korea stocks is notably lower than that of the firm.
KNOTUS CoLtd Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining KNOTUS CoLtd's current stock value. Our valuation model uses many indicators to compare KNOTUS CoLtd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across KNOTUS CoLtd competition to find correlations between indicators driving KNOTUS CoLtd's intrinsic value. More Info.KNOTUS CoLtd is rated third in return on equity category among its peers. It also is rated third in profit margin category among its peers fabricating about 0.02 of Profit Margin per Return On Equity. The ratio of Return On Equity to Profit Margin for KNOTUS CoLtd is roughly 42.29 . Comparative valuation analysis is a catch-all model that can be used if you cannot value KNOTUS CoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for KNOTUS CoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About KNOTUS CoLtd Financial Statements
KNOTUS CoLtd stakeholders use historical fundamental indicators, such as KNOTUS CoLtd's revenue or net income, to determine how well the company is positioned to perform in the future. Although KNOTUS CoLtd investors may analyze each financial statement separately, they are all interrelated. For example, changes in KNOTUS CoLtd's assets and liabilities are reflected in the revenues and expenses on KNOTUS CoLtd's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in KNOTUS CoLtd. Please read more on our technical analysis and fundamental analysis pages.
It offers platform technology services, such as cell-enzyme-based screening, xenograft assay, mitogenic effect test, vaccine antigen, antibody titration, cytokine, MRNA expression, trachea relaxation assay, carrageenan, adjuvant induced paw edema, antipyretic, anti-pain test, isolated blood vessel screening, fibrin plate lysis screening, ferric chloride induced model, food diet induced model, gastric acid secretion, emesis model, MIC test, post antibody effect, enzyme assay, systemic, local infection model, PK study, chemical, transgenic animal, osteoblast-like cell line screening, bone formation marker, and biomarker. The company also provides pharmacokinetictoxico study, toxicology study, and biological drug and toxicclinical pathology services. KNOTUS is traded on Korean Securities Dealers Automated Quotations in South Korea.
Pair Trading with KNOTUS CoLtd
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if KNOTUS CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KNOTUS CoLtd will appreciate offsetting losses from the drop in the long position's value.Moving together with KNOTUS Stock
Moving against KNOTUS Stock
| 0.68 | 041510 | SM Entertainment | PairCorr |
| 0.64 | 035420 | Naver | PairCorr |
| 0.55 | 078160 | MEDIPOST | PairCorr |
| 0.55 | 011390 | Busan Industrial | PairCorr |
| 0.47 | 032640 | LG Uplus | PairCorr |
The ability to find closely correlated positions to KNOTUS CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace KNOTUS CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back KNOTUS CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling KNOTUS CoLtd to buy it.
The correlation of KNOTUS CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as KNOTUS CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if KNOTUS CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for KNOTUS CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in KNOTUS Stock
KNOTUS CoLtd financial ratios help investors to determine whether KNOTUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KNOTUS with respect to the benefits of owning KNOTUS CoLtd security.